ニュース

最新ニュース

Friendly musical evening for economic partners between Japan and Belgium

Newton Biocapital’s Successful Flagey Music & Cocktail Networking Evening

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Acticor Biotech announces the appointment of Corinne Le Goff to the Board of Directors as an independent director

Acticor Biotech announces positive results from its ACTIMIS phase 1b/2a study in patients with Acute Ischemic Stroke (AIS)

ニュートンバイオキャピタル、当初出資約束金額5000万ユーロ・目標規模1億5000万ユーロのファンドを新たに設立

Newton Biocapital launches a new fund with initial capital commitments of EUR 50 million and target size of EUR 150 million.

Epics Therapeutics Initiates First-in-Human Studies with EP282, an oral Investigational Drug for the treatment of gastrointestinal inflammatory disorders and cancer

PRISM、Roche社とGenentech社と共同研究・ライセンス契約を締結

1
2
3